MedPath
FDA Approval

ARGATROBAN

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Accord Healthcare Inc.
DUNS: 604222237
Effective Date
November 7, 2022
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Argatroban(1 mg in 1 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Intas Pharmaceuticals Limited

Accord Healthcare Inc.

725927649

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ARGATROBAN

Product Details

NDC Product Code
16729-430
Application Number
NDA212035
Marketing Category
NDA (C73594)
Route of Administration
INTRAVENOUS
Effective Date
November 7, 2022
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACTQuantity: 9 mg in 1 mL
SORBITOLInactive
Code: 506T60A25RClass: IACTQuantity: 3 mg in 1 mL
Code: IY90U61Z3SClass: ACTIBQuantity: 1 mg in 1 mL
© Copyright 2025. All Rights Reserved by MedPath